Sign up

Invenomic Capital Management LP

$1.7B assets · 115 holdings · Q2 2026 · Filed 14 AUG 2026

About Invenomic Capital Management LP’s 13F portfolio

Invenomic Capital Management LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Invenomic Capital Management LP reported $1.7B across 115 US-listed positions (). Its largest position is GLOBAL PMTS INC (GPN) at 3.8% of the reported book, and its ten biggest holdings make up 29% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$1.7B
Assets (13F)
#1,686
of 8,845 by size
115
Holdings
29%
Top-10 weight
44
Buys
122
Sells
Top holdings · Q2 2026
115 total
#StockPrice% of portfolioSharesValue
1
NYSE: GPN
GLOBAL PMTS INC
—
—
3.8%
882K$64.0M
2
NYSE: UHS
UNIVERSAL HLTH SVCS INC
—
—
3.8%
427K$63.5M
3
NASDAQ: WDAY
WORKDAY INC
—
—
3.5%
476K$58.3M
4
NASDAQ: XRAY
DENTSPLY SIRONA INC
—
—
3.1%
4.9M$52.1M
5
NASDAQ: SPSC
SPS COMM INC
—
—
3.0%
869K$49.7M
6
NYSE: PVH
PVH CORPORATION
—
—
2.6%
575K$42.7M
7
NYSE: BDX
BECTON DICKINSON & CO
—
—
2.5%
273K$41.3M
8
NYSE: FIS
FIDELITY NATL INFORMATION SV
—
—
2.5%
1.1M$41.2M
9
NASDAQ: CHTR
CHARTER COMMUNICATIONS INC
—
—
2.4%
282K$40.2M
10
NYSE: EGO
ELDORADO GOLD CORP NEW
—
—
2.2%
1.2M$36.0M
11
NYSE: OMC
OMNICOM GROUP INC
—
—
2.1%
479K$34.9M
12
NASDAQ: LYFT
LYFT INC
—
—
2.1%
2.4M$34.3M
13
NYSE: BILL
BILL HOLDINGS INC
—
—
2.0%
909K$32.9M
14
NYSE: CLVT
CLARIVATE PLC
—
—
1.8%
14.3M$30.8M
15
NYSE: CRM
SALESFORCE INC
—
—
1.8%
193K$30.3M
16
NYSE: INGM
INGRAM MICRO HLDG CORP
—
—
1.8%
1.1M$29.6M
17
NASDAQ: INTU
INTUIT
—
—
1.7%
107K$27.8M
18
NASDAQ: VTRS
VIATRIS INC
—
—
1.6%
1.7M$27.6M
19
NYSE: CNMD
CONMED CORP
—
—
1.6%
842K$27.6M
20
NYSE: OC
OWENS CORNING NEW
—
—
1.5%
161K$25.5M
21
NASDAQ: FISV
FISERV INC
—
—
1.5%
520K$25.5M
22
NYSE: SON
SONOCO PRODS CO
—
—
1.5%
438K$24.7M
23
NYSE: ABM
ABM INDS INC
—
—
1.4%
532K$23.5M
24
NYSE: NOMD
NOMAD FOODS LTD
—
—
1.4%
2.1M$22.9M
25
NYSE: ST
SENSATA TECHNOLOGIES HLDG PL
—
—
1.3%
470K$22.4M

Showing 1–25 of 115 positions on this page reported in this 13F.

Sector allocation
  • Technology32%
  • Healthcare19%
  • Industrials14%
  • Consumer Cyclical10%
  • Communication Services8.0%
  • Consumer Defensive7.4%
  • Basic Materials3.9%
  • Financial Services2.8%
  • Real Estate0.4%
  • Utilities0.4%
Recent activity · vs 2026-03-31
Bought44
  • AddedUHSUNIVERSAL HLTH SVCS INC+131%$63.5M
  • AddedXRAYDENTSPLY SIRONA INC+11.8%$52.1M
  • AddedSPSCSPS COMM INC+229%$49.7M
  • NewBDXBECTON DICKINSON & CO—$41.3M
  • AddedFISFIDELITY NATL INFORMATION SV+2.6%$41.2M
  • NewCHTRCHARTER COMMUNICATIONS INC—$40.2M
  • AddedOMCOMNICOM GROUP INC+7.2%$34.9M
  • AddedCLVTCLARIVATE PLC+7.1%$30.8M
  • NewINTUINTUIT—$27.8M
  • AddedNOMDNOMAD FOODS LTD+6.9%$22.9M
Sold122
  • ReducedGPNGLOBAL PMTS INC−3.6%$64.0M
  • ReducedWDAYWORKDAY INC−15.0%$58.3M
  • ReducedPVHPVH CORPORATION−24.6%$42.7M
  • ReducedEGOELDORADO GOLD CORP NEW−19.3%$36.0M
  • ReducedLYFTLYFT INC−19.7%$34.3M
  • ReducedBILLBILL HOLDINGS INC−12.1%$32.9M
  • ReducedCRMSALESFORCE INC−13.5%$30.3M
  • ReducedINGMINGRAM MICRO HLDG CORP−21.9%$29.6M
  • ReducedVTRSVIATRIS INC−46.2%$27.6M
  • ReducedCNMDCONMED CORP−9.9%$27.6M

Reading Invenomic Capital Management LP’s 13F portfolio

Invenomic Capital Management LP’s $1.7B 13F book is spread across 115 reported positions and is moderately diversified, the ten largest names accounting for 29%. There are meaningful positions at the top alongside a long tail of smaller holdings. Its five largest positions are GPN, UHS, WDAY, XRAY and SPSC, led by GLOBAL PMTS INC (GPN) at 3.8% of the portfolio. The heaviest sector exposure is Technology (32%), then Healthcare (19%).

What Invenomic Capital Management LP changed last quarter

Between 2026-03-31 and Q2 2026, Invenomic Capital Management LP was a net seller: it opened 21 new positions and added to 23 more, while trimming 68 and closing 54 outright. Against a 115-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was UNIVERSAL HLTH SVCS INC (UHS), and its biggest reduction was GLOBAL PMTS INC (GPN).

What a 13F does and doesn’t reveal

A 13F captures only Invenomic Capital Management LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Invenomic Capital Management LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Invenomic Capital Management LP's profile on this page is built directly from those filings.

How current is the 13F data on Invenomic Capital Management LP's page?

It reflects Invenomic Capital Management LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Invenomic Capital Management LP files its next quarterly report, this page refreshes automatically.

Can I see Invenomic Capital Management LP's complete list of holdings?

This page highlights Invenomic Capital Management LP's largest positions rather than all 115 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Invenomic Capital Management LP's filings.

Does a 13F show everything Invenomic Capital Management LP owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Invenomic Capital Management LP's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Invenomic Capital Management LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.